E
ReShape Lifesciences Inc. RSLS
$0.6355 $0.00050.08%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Revenue 8.18M 8.05M 8.34M 8.68M 9.81M
Total Other Revenue -- -- -- -- --
Total Revenue 8.18M 8.05M 8.34M 8.68M 9.81M
Cost of Revenue 2.60M 2.62M 2.85M 3.13M 4.50M
Gross Profit 5.58M 5.43M 5.49M 5.55M 5.31M
SG&A Expenses 11.48M 12.53M 14.36M 17.87M 21.24M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 16.10M 17.31M 19.55M 23.32M 27.78M
Operating Income -7.92M -9.26M -11.22M -14.64M -17.98M
Income Before Tax -7.00M -8.96M -10.87M -11.34M -26.19M
Income Tax Expenses 66.00K 63.00K 52.00K 52.00K -35.00K
Earnings from Continuing Operations -7.07 -9.02 -10.92 -11.39 -26.16
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -7.07M -9.02M -10.92M -11.39M -26.16M
EBIT -7.92M -9.26M -11.22M -14.64M -17.98M
EBITDA -7.90M -9.19M -11.11M -14.48M -17.31M
EPS Basic -18.59 -74.84 -133.53 -218.49 -212.09
Normalized Basic EPS -12.11 -39.09 -75.49 -128.32 -124.40
EPS Diluted -18.59 -74.84 -133.53 -218.49 -212.09
Normalized Diluted EPS -12.11 -39.09 -75.49 -128.32 -124.40
Average Basic Shares Outstanding 1.61M 1.16M 785.40K 410.50K 145.00K
Average Diluted Shares Outstanding 1.61M 1.16M 785.40K 410.50K 145.00K
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings